Rebecca Torrence is a Senior Healthcare Reporter for Business Insider and Entrepreneur Media. With a background in digital health reporting, Rebecca covers a wide range of topics in the healthcare industry, including startups, technology, and industry trends. Her work has been featured in Insider and she is known for her in-depth reporting and analysis.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Rebecca Torrence's coverage is heavily focused on the healthcare and pharmaceutical industry, particularly pertaining to startups, weight-loss programs, pharmaceutical companies, and AI in biotech. Her articles largely feature press releases and private sector announcements along with citations of data.
Considering her focus on these specific sectors within healthcare and reliance on official announcements or data-driven content, she would likely be interested in pitches that provide exclusive insights into new developments or trends within the healthcare startup space. Providing access to expert analysis or insider perspectives related to weight-loss programs, pharmaceutical advancements, AI applications in biotech, or emerging trends within the healthcare industry could pique her interest.
Given Rebecca's lack of a specified geographic focus but apparent broad international view of the healthcare industry topics she covers - such as weight loss programs - relevant sources from any location may find appeal when reaching out.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Rebecca Torrence
Cherish Health has raised $26 million to bring its radar-based fall detection device to market.
By: Rebecca Torrence
Transcarent, the healthcare startup led by Livongo founder Glen Tullman, is raising fresh cash at a $2.1 billion valuation.
By: Rebecca Torrence
Georgiamune is testing new drugs for cancer and autoimmune disorders with $75 million in Series A funding from investors like General Catalyst.
By: Rebecca Torrence
Pelago just grabbed a $58 million Series C led by Atomico to expand care for substance use disorders. It could reach profitability after this raise.
By: Shelby Livingston, Rebecca Torrence
Surescripts is up for sale and has hired a bank to search for potential buyers, including private equity firms.
By: Rebecca Torrence
Cerebral's investors are fighting as the once-hot mental health company tumbles. Access Industries is suing the company and another investor, WestCap, in an alleged power struggle.
By: Rebecca Torrence
Healthcare AI startups are raising at high valuations this year as other healthtech deals stabilize.
By: Rebecca Torrence
Two Chairs just grabbed $72 million of Series C equity and debt funding led by Amplo. The telehealth startup matches patients with therapists for individual and group counseling.
By: Rebecca Torrence
The health-focused VC firm is making bets out of its second $65 million fund. Here's what a startup needs to get its backing.
By: Rebecca Torrence
VC firm Redesign Health is targeting $250 million in its latest fundraising push. The health-focused investor and accelerator last raised $65 million in September 2022.
(833) 317-6278 
